Share:
Peer-Reviewed Publication
Clin Neurophysiol2024;163174-184.July 1, 2024Systematic Review

Relationship between event-related potentials and cognitive dysfunction in multiple sclerosis: A systematic review.

Joana Almeida Ferreira1, Nuno Pinto2, Tiago Maricoto3, Maria Vaz Pato4
1Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal; Neurology Department, Hospital Garcia de Orta, Almada, Portugal.
2Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal; CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; GRUBI - University of Beira Interior Systematic Reviews Group, Covilhã, Portugal. Electronic address: nuno.pinto@fcsaude.ubi.pt.
3Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal; CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; GRUBI - University of Beira Interior Systematic Reviews Group, Covilhã, Portugal; Beira Ria Health Center, Aveiro Health Centre, Ílhavo, Portugal.
4Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal; CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; GRUBI - University of Beira Interior Systematic Reviews Group, Covilhã, Portugal.

Abstract

OBJECTIVE: This systematic review aimed to evaluate if event-related potentials (ERPs) can be a relevant tool for cognitive dysfunction diagnosis in Multiple Sclerosis (MS). METHODS: Four databases were consulted (PubMed, Embase, Scielo, and Web of Science). The included studies should include adults with clear MS diagnoses, independently of having cognitive complaints, and all should have been s…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.